Thibaud Prawitz
Thibaud Prawitz publishes mostly in Economics and Econometrics, Hematology and Statistics and Probability, on topics such as Health Systems, Economic Evaluations, Quality of Life, Multiple Myeloma Research and Treatments and Pharmaceutical Economics and Policy.
- World rank
- #5,997,938 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #335,657 of 367,258
- Works
- 28
- Citations
- 82
- Citations per work
- 2.9
What does Thibaud Prawitz research?
Thibaud Prawitz's work is mostly in Medicine (26%), Economics, Econometrics and Finance (24%), Mathematics (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1034.7%
- Health Sciences726.4%
- Medicine726.4%
- Social Sciences723.6%
- Physical Sciences311.1%
- Mathematics311.1%
- Life Sciences14.2%
- 1Economics and Econometrics24% of their works
- 2Hematology11% of their works
- 3Statistics and Probability11% of their works
- 4Oncology10% of their works
- 5Surgery6% of their works
- 6Molecular Biology4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Pharmaceutical Economics and Policy
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
- Acute Lymphoblastic Leukemia research
- Protein Degradation and Inhibitors
- Statistical Methods and Inference
Which keywords describe Thibaud Prawitz's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Minimal Residual Disease, Bayesian Methods, Diagnosis Criteria, International Myeloma Working Group, Drug Development Costs and Generic Drugs.
- Variable Selection
- PROTACs
- Propensity Score
- Childhood Cancer
- Adaptive Designs
- Generic Drugs
- International Myeloma Working Group
- Bayesian Methods
- Quality of Life
- Cost-effectiveness Analysis
- Minimal Residual Disease
- Diagnosis Criteria
- Drug Development Costs
- Acute Lymphoblastic Leukemia
- Causal Inference
- False Discovery Rate
- BET Bromodomains
- Regularization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
- Minimal Residual Disease82 topics
- Bayesian Methods52 topics
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- Drug Development Costs41 topic
- Generic Drugs41 topic
- Acute Lymphoblastic Leukemia31 topic
- Adaptive Designs31 topic
- Causal Inference31 topic
- Childhood Cancer31 topic
- False Discovery Rate31 topic
- Propensity Score31 topic
- BET Bromodomains21 topic
- PROTACs21 topic
- Regularization21 topic
- Variable Selection21 topic
Where does Thibaud Prawitz work?
Thibaud Prawitz's main affiliation in the publication record is EVRAZ (United Kingdom), United Kingdom.
How many publications and citations does Thibaud Prawitz have?
OpenAlex counts 28 works and 82 citations for Thibaud Prawitz, an h-index of 5, ranking #5,997,938 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thibaud Prawitz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.